-
Budesonide Prophylaxis--Immunotherapy-induced diarrhea
-
Vedolizumab: Unresolved or Refractory Diarrhea - Immunotherapy Induced Diarrhea
Budesonide Prophylaxis for IID
Budesonide is a corticosteroid that decreases inflammation in the digestive tract associated with diarrhea. It is a treatment option for Crohn's disease. Budesonide has been studied as prophylaxis for immune checkpoint inhibitor related enterocolitis. Research findings do not support Budesonide prophylaxis in this setting.
Vedolizumab: Unresolved or Refractory Diarrhea for IID
Vedolizumab is an integrin receptor antagonist indicated for treatment of inflammatory bowel disease. It has been studied in the treatment of immune-mediated diarrhea and colitis with favorable results in response, reduced hospitalizations and shorter steroid use duration.
-
Dietary Fiber
Dietary Fiber for RID
Modification of dietary fiber has been studied for management of cancer treatment-related diarrhea and gastrointestinal toxicity.
-
Sulfasalazine - Radiation Induced Diarrhea
Sulfasalazine for RID
Sulfasalazine is a disease-modifying antirheumatic drug FDA approved for treatment of rheumatic arthritis, polyarticular juvenile idiopathic arthritis, and ulcerative colitis. Sulfasalazine has been studied for it's effect on radiation induced diarrhea.
